Chunyan Lan

2.1k total citations · 1 hit paper
61 papers, 1.4k citations indexed

About

Chunyan Lan is a scholar working on Reproductive Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chunyan Lan has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Reproductive Medicine, 17 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chunyan Lan's work include Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Chunyan Lan is often cited by papers focused on Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Chunyan Lan collaborates with scholars based in China, United Kingdom and Hong Kong. Chunyan Lan's co-authors include Xin Huang, Jihong Liu, Suxia Lin, Qi-Chun Cai, Jiabin Lu, Ming Hung Wong, W.S. Shu, Z.H. Ye, Bowen Yang and Ting Wan and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Chunyan Lan

54 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation

2022 137 citations Chunyan Lan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chunyan Lan China	18	436	329	288	204	162	61	1.4k
Zhiqiang Guo China	20	408 0.9×	497 1.5×	310 1.1×	139 0.7×	128 0.8×	56	1.5k
Moncef Mokni Tunisia	21	485 1.1×	340 1.0×	111 0.4×	71 0.3×	276 1.7×	189	1.7k
Akihiko Maekawa Japan	25	235 0.5×	444 1.3×	176 0.6×	167 0.8×	123 0.8×	112	2.0k
Giovanna Giordano Italy	22	367 0.8×	326 1.0×	86 0.3×	392 1.9×	282 1.7×	116	1.8k
Tao Lin China	32	360 0.8×	1.4k 4.1×	308 1.1×	301 1.5×	481 3.0×	153	3.0k
Andrzej Kulig Poland	19	445 1.0×	345 1.0×	179 0.6×	75 0.4×	219 1.4×	156	1.4k
Peter Young United States	21	148 0.3×	225 0.7×	145 0.5×	292 1.4×	132 0.8×	59	1.5k
Sun China	18	318 0.7×	364 1.1×	117 0.4×	34 0.2×	312 1.9×	305	1.4k
Cláudio J. Maia Portugal	22	229 0.5×	634 1.9×	157 0.5×	81 0.4×	257 1.6×	69	1.7k
Vasiliki Malamou‐Mitsi Greece	24	319 0.7×	418 1.3×	111 0.4×	61 0.3×	453 2.8×	47	1.7k

Countries citing papers authored by Chunyan Lan

Since Specialization

Citations

This map shows the geographic impact of Chunyan Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunyan Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunyan Lan more than expected).

Fields of papers citing papers by Chunyan Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunyan Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunyan Lan. The network helps show where Chunyan Lan may publish in the future.

Co-authorship network of co-authors of Chunyan Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Chunyan Lan. A scholar is included among the top collaborators of Chunyan Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunyan Lan. Chunyan Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Shu‐Qiang, Shuai He, Tao Xia, et al.. (2025). Super-enhancer–driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis. Journal of Clinical Investigation. 135(8). 2 indexed citations

Wang, Shuqing, et al.. (2025). Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer. Cellular Oncology. 48(5). 1513–1522.

Lan, Chunyan, Huaiwu Lu, Junxiu Liu, et al.. (2024). Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study. Cancer Communications. 44(6). 654–669. 5 indexed citations

Zhang, Kaina, Junzhou Zhang, Chun Li, Shan Li, & Chunyan Lan. (2024). Combined Jamming Method of Chaff and Corner Reflector Against Anti-ship Missiles. 342–346. 2 indexed citations

Lan, Chunyan, Ying Peng, Yue Li, et al.. (2024). Spatially lipidomic characterization of patient-derived organoids by whole-mount autofocusing SMALDI mass spectrometry imaging. Analytica Chimica Acta. 1325. 342989–342989. 2 indexed citations

Lan, Chunyan, Jing Li, Shanshan Lian, et al.. (2024). Pamiparib in combination with surufatinib among patients with platinum-resistant ovarian cancer who received prior PARP inhibitors: A multicenter, single-arm, phase Ib/II trial (POST-PARPi Trial). Gynecologic Oncology. 190. S291–S291.

Zhou, Hong, Yanxia Wang, Min Wu, et al.. (2024). FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis. The Journal of Pathology. 262(4). 427–440. 7 indexed citations

Peng, Ying, Kexin Ma, Chunyan Lan, et al.. (2024). Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer. BMC Genomics. 25(1). 250–250. 4 indexed citations

Lan, Chunyan, et al.. (2023). Radar radiation identification based on online transfer learning. 41. 173–173. 1 indexed citations

10.

Wan, Ting, Yun Zhou, Shuting Huang, et al.. (2023). The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages. Cancer Cell International. 23(1). 248–248. 13 indexed citations

11.

Liu, Shu, et al.. (2023). Development and validation of a sensitive LC–MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients. Journal of Pharmaceutical and Biomedical Analysis. 237. 115758–115758. 6 indexed citations

12.

Lan, Chunyan, et al.. (2023). Long-term survival outcomes and immune checkpoint inhibitor (ICI) retreatment in patients with advanced cervical cancer who received camrelizumab plus apatinib in the CLAP study.. Journal of Clinical Oncology. 41(16_suppl). e17513–e17513. 1 indexed citations

13.

Lan, Chunyan, Jing Zhao, Fan Yang, et al.. (2022). Anlotinib combined with TQB2450 in patients with platinum-resistant or -refractory ovarian cancer: A multi-center, single-arm, phase 1b trial. Cell Reports Medicine. 3(7). 100689–100689. 26 indexed citations

14.

Lan, Chunyan, Wang Yin, Ying Xiong, et al.. (2018). Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study. The Lancet Oncology. 19(9). 1239–1246. 134 indexed citations

15.

Zhou, Yun, et al.. (2015). Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits. Drug Design Development and Therapy. 9. 5949–5949. 3 indexed citations

16.

Lan, Chunyan, Xin Huang, Qidan Huang, et al.. (2015). Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?. International Journal of Gynecological Cancer. 25(8). 1445–1452. 1 indexed citations

17.

Lan, Chunyan, Xin Huang, Suxia Lin, et al.. (2013). High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. Cell and Tissue Research. 352(2). 351–359. 55 indexed citations

18.

Hong, Huachang, Hong-Juan Zhou, Chunyan Lan, & Yanshan Liang. (2010). Pentachlorophenol induced physiological–biochemical changes in Chlorella pyrenoidosa culture. Chemosphere. 81(10). 1184–1188. 5 indexed citations

19.

Lan, Chunyan, Yanfang Li, & Jihong Liu. (2009). Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer. Gynecologic Oncology. 114(1). 42–47. 13 indexed citations

20.

Yang, Bowen, W.S. Shu, Z.H. Ye, Chunyan Lan, & Ming Hung Wong. (2003). Growth and metal accumulation in vetiver and two Sesbania species on lead/zinc mine tailings. Chemosphere. 52(9). 1593–1600. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact